Ardelyx (ARDX) Receivables - Net (2013 - 2026)
Ardelyx (ARDX) reported Receivables - Net of $82.8 million for Q1 2026, up 78.28% on a YoY basis from $46.5 million in Q1 2025, and up 15.3% quarter-over-quarter from $71.8 million in Q4 2025.
Ardelyx (ARDX) Receivables - Net (2013 - 2026) Analysis & Trends
Ardelyx has reported Receivables - Net for 12 years, with the latest figure at $82.8 million in Q1 2026.
- For the quarter ending Q1 2026, Receivables - Net rose 78.28% year-over-year to $82.8 million; the trailing twelve-month figure through Mar 2026 stood at $82.8 million (up 78.28% YoY), and the FY2025 full-year result was $71.8 million, up 24.51% from the prior year.
- Receivables - Net for Q1 2026 stood at $82.8 million, up from $71.8 million in the prior quarter.
- The five-year high for Receivables - Net was $82.8 million in Q1 2026, with the low at $4.4 million in Q1 2022.
- Historically, Receivables - Net has averaged $36.8 million across 5 years, with a median of $37.2 million in 2024.
- The largest YoY upside for Receivables - Net was 1714.63% in 2022 against a maximum downside of 24.02% in 2022.
- Ardelyx's Receivables - Net stood at $7.7 million in 2022, then jumped by 184.9% to $22.0 million in 2023, then surged by 161.93% to $57.7 million in 2024, then rose by 24.51% to $71.8 million in 2025, then climbed by 15.3% to $82.8 million in 2026.
- The last three Receivables - Net figures came in at $82.8 million (Q1 2026), $71.8 million (Q4 2025), and $76.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 82.84 Mn |
| Mar 31, 2026 | 82.84 Mn |
| Dec 31, 2025 | 71.85 Mn |
| Dec 31, 2025 | 71.85 Mn |
| Sep 30, 2025 | 76.61 Mn |
| Sep 30, 2025 | 76.61 Mn |
| Jun 30, 2025 | 62.55 Mn |
| Jun 30, 2025 | 62.55 Mn |
| Mar 31, 2025 | 46.47 Mn |
| Mar 31, 2025 | 46.47 Mn |
| Dec 31, 2024 | 57.71 Mn |
| Dec 31, 2024 | 57.71 Mn |
| Sep 30, 2024 | 53.20 Mn |
| Sep 30, 2024 | 53.20 Mn |
| Jun 30, 2024 | 37.24 Mn |
| Jun 30, 2024 | 37.24 Mn |
| Mar 31, 2024 | 28.16 Mn |
| Mar 31, 2024 | 28.16 Mn |
| Dec 31, 2023 | 22.03 Mn |
| Dec 31, 2023 | 22.03 Mn |